Pluvicto (lutetium Lu 177 vipivotide tetraxetan) is a medicine that is used to treat prostate cancer in adults. Pluvicto may be used to treat PSMA-positive prostate cancer that has spread to other ...

The American Cancer Society estimates that 288,300 new cases of prostate cancer will be diagnosed in 2023. While the overall ...

Prostate cancer screening for men over 70 is complex, with current recommendations against routine PSA testing due to slow growth and treatment side effects. However, evolving life expectancies prompt ...

Investigators analyzed exfoliated cells in urine test specimens to identify 50 candidate RNAs for prostate cancer detection.

Solution/product: The company is developing two diagnostics for prostate cancer, according to a company statement. Its lead test is designed to use prostate cancer biopsy tissue to help physicians ...

Conventional imaging methods have limited sensitivity for detecting metastatic prostate cancer. With appropriate, timely treatment vital to survival and quality of life, better imaging has been an ...

News of the study comes days after it emerged an NHS trial will use AI to interpret MRI scans from men suspected of having ...

Many Black men are not given the novel hormone therapies that have become a game changer in the treatment of people with advanced prostate cancer. Recent advances in treatment, notably the new hormone ...

Researchers from Rice University and Vanderbilt University have made significant advancements in the fight against prostate cancer. They have shown that combining a small-molecule therapy called tumor ...